Table 3: Overview of NE status of TRAMP DIO study tumors.

GroupPercent NE positiveNE statusInitial body weightBody weight increase (6–18 weeks)Final body weightAge at tumor detectionAge at deathGUT weightHigh grade (%)

Obesity prone37% (7/19)Positive20.8 ± 0.914.1 ± 0.639.1 ± 2.7 (100)x 7/7
Negative20.8 ± 0.713.1 ± 0.443.9 ± 2.131.4 ± 0.946.3 ± 0.911.4 ± 0.9(18) 2/11
Overweight21% (3/14)Positive22.8 ± 1.19.5 ± 0.4 9.5 ± 0.8(100) 2/2
Negative21.7 ± 0.59.5 ± 0.241.2 ± 1.233.7 ± 1.644.6 ± 1.59.9 ± 1.0(56) 5/9
Obesity resistant46% (6/13)Positive21.1 ± 0.57.2 ± 0.735.0 ± 2.726.7 ± 2.635.0 ± 4.67.7 ± 1.6(100) 6/6
Negative22.3 ± 0.58.0 ± 0.240.6 ± 3.529.3 ± 1.642.1 ± 2.99.4 ± 10.5(57) 4/7
All high-fat diet mice35% (16/46)Positive21.3 ± 0.510.2 ± 0.8 (100)x 15/15
Negative21.5 ± 0.311.0 ± 0.442.1 ± 1.231.8 ± 0.844.7 ± 0.910.4 ± 0.6(41) 11/27
Low fat35% (6/17)Positive19.7 ± 1.38.1 ± 1.836.6 ± 2.7 (100)x 6/6
Negative21.2 ± 0.68.0 ± 0.739.7 ± 1.731.7 ± 1.245.8 ± 1.610.4 ± 1.0(20) 2/10

A significant difference ( ) within each group is designated as x.